Science and Medicine Group

Instrument Business Outlook Volume 32 - Issue 19: Annual 2024 Forecast 17 Jan 2024

Report details
33 Figures
21 Tables

The IBO 2024 Market Forecast
- 2023
- 2024
- Economic Overview
Life Science Instrumentation: A Bumpy Road Ahead
The Mass Spectrometry Market to Experience Slower Growth in 2024
Gloomy Market Pressures Chromatography
Lab Automation: End-Market Lethargy Mutes Software Growth Prospects
Surface Science Growth Slows on the Wings on Weakening China and Pharma Growth
Molecular Spectroscopy Bridges Contrasts: Understanding Pharma & Biotech Softnes…
Atomic Spectroscopy: Market Favors Techniques with Broad Applications and Better…
Sample Preparation: Destocking Reins in Growth
Materials Characterization: Advanced Materials in the Driver’s Seat
Lab Equipment Markets to Move from Flat to Growth in 2024
End-Market Forecast: Pharma Begins its Recovery, Industrial Customers Cool
Regional Forecast: Asia (Excluding China and Japan) Offers Greatest Potential
2023 Trends and Developments
- China’s Surprising Turn
- Pharma & Biotech’s Pause
- Shareholders Make Noise
- Funding Troubles Remain
- Workforce Reductions
Executive Briefing
- Ilumina Acquires Partek
- Standard BioTools and SomaLogic Complete Merger
- Biotage CEO Steps Down
- Dotmatics Makes 13th Acquisition
- NanoString Further Reduces Workforce
- ABB Buys Water Quality Monitoring Technology Company
- Calibre Scientific Acquires German Supplier
- Mabtech Sold
- Parse Expands to Software
- LIMS Vendors Form New Company
- Oxford Instruments Buys Scientific Camera Company
- Flow Reactor Maker Sold
J.P. Morgan Healthcare Conference 2024: Lab Tool Companies Provide Updates and…
- Illumina
- Bruker
- NanoString Technologies
- Agilent, Danaher, Revvity, Thermo Fisher Scientific and Waters

Attachments

IBO 011724 Issue.pdf

Instrument Business Outlook Volume 32 - Issue 19: Annual 2024 Forecast

17 Jan 2024

Request Access

Table of Contents

The IBO 2024 Market Forecast
- 2023
- 2024
- Economic Overview
Life Science Instrumentation: A Bumpy Road Ahead
The Mass Spectrometry Market to Experience Slower Growth in 2024
Gloomy Market Pressures Chromatography
Lab Automation: End-Market Lethargy Mutes Software Growth Prospects
Surface Science Growth Slows on the Wings on Weakening China and Pharma Growth
Molecular Spectroscopy Bridges Contrasts: Understanding Pharma & Biotech Softness and Academic Growth
Atomic Spectroscopy: Market Favors Techniques with Broad Applications and Better Performance
Sample Preparation: Destocking Reins in Growth
Materials Characterization: Advanced Materials in the Driver’s Seat
Lab Equipment Markets to Move from Flat to Growth in 2024
End-Market Forecast: Pharma Begins its Recovery, Industrial Customers Cool
Regional Forecast: Asia (Excluding China and Japan) Offers Greatest Potential
2023 Trends and Developments
- China’s Surprising Turn
- Pharma & Biotech’s Pause
- Shareholders Make Noise
- Funding Troubles Remain
- Workforce Reductions
Executive Briefing
- Ilumina Acquires Partek
- Standard BioTools and SomaLogic Complete Merger
- Biotage CEO Steps Down
- Dotmatics Makes 13th Acquisition
- NanoString Further Reduces Workforce
- ABB Buys Water Quality Monitoring Technology Company
- Calibre Scientific Acquires German Supplier
- Mabtech Sold
- Parse Expands to Software
- LIMS Vendors Form New Company
- Oxford Instruments Buys Scientific Camera Company
- Flow Reactor Maker Sold
J.P. Morgan Healthcare Conference 2024: Lab Tool Companies Provide Updates and Reflect on End-Market Strength
- Illumina
- Bruker
- NanoString Technologies
- Agilent, Danaher, Revvity, Thermo Fisher Scientific and Waters